RESUSITASI RUMATAN
• ASERING
1 L of • Lactated Ringer’s
• Normal saline
Replace acute/
increases ECF abnormal
loss
800 ml 200 ml
ASERING
® First Line
Ringer’s acetate
Fluid Resuscitation
Therapy
Acetate Ringer’s
1. Metabolisme asetat terutama di otot, tidak dipengaruhi fungsi hati. (1)
1. Loren A et al. Oxidation of lactate and acetate in rat skeletal muscle. Journal of Applied
Physiology 1997 ; 83 ( 1 ) : p. 32 - 39 .
2. Heimberger DC, M. Roland RW. Handbook of Clinical Nutrition. Mosby 1997
3. Anderud T, Lund T. Intensive Care of Patients with Burns. Tidskr Nor Laegenforen 1989;
p. 3197 - 3199.
4. Ringer acetate solution in clinical practice. Medimedia. 1999
4
ASERING ®
Acetated Ringer's
First Line Fluid Resuscitation Therapy
9
CAIRAN KRISTALOID ISOTONIK
RESUSITASI RUMATAN
KA-EN 3B - AMINOFLUID/
Maintenance sol
Replace Normal
increases ICF > ECF loss (IWL + urine)
660 ml 255 ml 85 ml
Ilustrasi BB Dewasa (Org Indonesia) : ± 50 kg
Infus RL bukan
Untuk Terapi Rumatan
表2.入退院時の血清内カリウム
レベル
PREVALENCES OF HYPOKALEMIA
Chief Investigator Centre No of % hypokalemia % hypokalemia
patients on admission on Discharge
1. Sudomo, Untung. Marissa Ira. Gastroenterogy hepatoloy and digestive endoscopy vol.5. Ed: Dec 2004. Page: 115-120
2. Widodo D, Setiawan B, Khie Chen. The prevalence of hypokalemia in hospitalized patients with infectious diseases problems at
Ciptomangun-kusumo Hospital Jakarta. Acta Med Indones, 2006;38(4):202-5
3. Nasronudin et al. The Prevalence of hypokalemia and Hyponatremia in Infectious Diseases Hospitalized Patients. Medika 2006 Vol
XXXII,No 12, p 732-734
Composition
Composition
Product
mOsm/
Na K Cl Lactate Glucose
Litre
Kaen 3A 60 10 50 20 27 290
Kaen 3B 50 20 50 20 27 290
Kaen 4A 30 - 20 10 40 282
AMINOFLUID®
Electrolytes, 7.5% Glucose, 3% Amino Acids
Practical and Complete Maintenance
Solution
for Better Clinical Outcome
AMINOFLUID®
Electrolytes, 7.5% Glucose, 3% Amino Acids
Amino Acids
3%
AMINOFLUID
®
Glucose Electrolytes
7.5 % (Na, K, Cl, Mg, Ca, P)
+Zinc
Komposisi 1000 mL :
Ingredients Composition Ingredients Composition
L-Isoleucine 2.4 Sodium 35
L-Leucine 4.2 Potassium 20
L-Lysine 3.15 Magnesium 5
Essential amino acid L-Methionine 1.17 Calcium 5
(g/1000 mL) L-Phenylalanine 2.1 Chloride 35
L-Threonine 1.71 Electrolytes Sulfate 5
L-Tryptophan 0.6 (mEq/L) Acetate 13
L-Valine 2.4 Gluconate 5
L-Alanine 2.4 Lactate 20
L-Arginine 3.15 Citrate 6
L-Histidine 1.5 Phosphorus (mmol/L) 10
L-Proline 1.5 Zinc (µmol/L) 5
Nonessential amino acid
L-Serine 0.9 Total amino acids 30 gr
(g/1000 mL) L-Tyrosine 1.5 BCAA (% in Total amino acids) 9 gr
Glycine 1.77 Dextrose 75 gr
L-Cysteine 0.3 Total energy in 1,000 mL 420 kcal
L-Glutamic acid 0.3 Osmolarity (mOsm/Lt) ± 817
L-Aspartic acid 0.3 pH ~6.7
Feature Benefit
Mengandung Na, K, Cl sesuai dengan - Mengatasi dehidrasi intraselluler
kebutuhan harian - Mencegah ketosis
- Mencegah gangguan elektrolit dan asam basa
Mengandung mikro mineral (Mg, Ca, P) - Menjaga metabolisme sel
Mengandung Zinc 5 mikro mol - Mempercepat penyembuhan jaringan
- Memperbaiki immunitas sel
Dilengkapi AA kualitas tinggi (diperkaya - Memacu sintesa protein tubuh
BCAA 9 gr/L, tinggi EAA) - Meningkatkan nafsu makan
Mengandung glukosa anhidrat 7.5%/L - Efek protein sparing
- Mempertahankan kadar gula normal (euglycemia)
Resuscitation Maintenance
AMIPAREN
First line Parenteral
Amino Acids for
Metabolic Stress and
Malnourished Conditions
AMIPAREN ®
10% Amino Acid
Elektrolit
Vol KH Energi Osm
PRODUK AA (g) (mEq/L)
(ml) (g) (kcal) (mOsm/L)
Na+ Asetat-
KIDMIN : Balanced Amino Acids for
Renal Failure
Mengandung 17 Asam Amino
- AAE = 52.05 g / L
- AANE = 20.00 g / L
- BCAA = 45.8 %
- Ratio E/N = 2.6 : 1
Total Asam Amino : 72.05 g / L
Osmolaritas : 608 mOsm / L
Volume : 200 ml / botol
Indikasi : untuk menggantikan
kehilangan protein pada GGA &
GGK
® Balanced Amino Acids for
KIDMIN
7,2 % amino acid infusion
Renal Failure
PROFIL KIDMIN LEBIH BAIK
DIBANDINGKAN PRODUK SEJENIS UNTUK
PASIEN GAGAL GINJAL
1. Mengandung AAE dan AANE dengan appropriate ratio
2.6 : 1 , sesuai anjuran “ Concensus Report : Expert
Working Group Report on Nutrition in Adult Patients with
Renal Insufficiency “ , sehingga lebih menjamin
tercapainya sasaran terapi nutrisi pada pasien gagal
ginjal 1 )
PROFIL KIDMIN LEBIH BAIK … con’t
3. Mengandung Arginin , untuk mencegah terjadinya
hiperamonemia akibat gangguan siklus urea 3 )
Ref : 3 ) Teraoka S, et.al : Adverse effects of arginine-free amino acid solution and new composition of amino acid solution in
uremic subjects. In Tanaka T, Okada A ( eds ) Nutritional Support in Organ Failure. Elsevier Science Publishers
1990.pp 405 – 422.
4 ) Hand book of Nutrition & the Kidney , Lippincott Williams & Wilkins , 4 th ed . 2002
®
KIDMIN Balanced Amino Acids for
7,2 % amino acid infusion
Renal Failure
PEMBERIAN KIDMIN®
• Gagal Ginjal Kronis
- PPN : 200 ml /hari
- TPN : 400 ml /hari
• Gagal Ginjal Akut ( sedang – berat )
- TPN : 600 ml / hari
Product Profile
AMINOLEBAN
AMINO ACIDS FOR THE
TREATMENT OF
HEPATIC ENCEPHALOPATHY
KOMPOSISI AMINOLEBAN
28.4 g BCAA/L INJ(500ML)
L-Valine 4.20 g L-Alanine 3.75 g
L-Leucine 5.50 g L-Arginine hydrochloride3.65 g
L-Isoleucine 4.50 g (as L-arginine) 3.02 g
L-Threonine 2.25 g L-Histidine hydrochloride1.60 g
L-Tryptophan 0.35 g (as L-histidine) 1.18 g
L-Methionine 0.50 g L-Proline 4.00 g
L-Phenylalanine 0.50 g L-Serine 2.50 g
L-Lysine hydrochloride
3.80 g L-Cysteine hydrochloride0.20 g
(as L-lysine) 3.04 g hydrate (as L-cysteine) 0.14 g
Glycine 4.50 g
30
Indikasi
• Terapi ensefalopati hepatik pada
penyakit hati kronis
Kontra Indikasi
• Gangguan fungsi ginjal yang berat
(urea & metabolit asam amino tidak dapat
diekskresi)
Dosis : 1 - 2 x botol/hari
– Drip intra vena (iv) : kecepatan 25 - 40 tetes/menit
32
OTSULIP 20 %
50 g Soybean Oil and 3 g Ovolecithin
Kandungan Ukuran
Soybean Oil 50 g
Ovolecithin 3 g
Glycerol 5.5 g
Sodium Hydroxide qs
Water for Inj qs sd 250 ml
Osmolaritas 350 mOsm/L
Kalori 500 kcal
OTSULIP 20 %
50 G SOYBEAN OIL AND 3 G OVOLECITHIN
Bermanfaat untuk :
- Sumber energi yang tinggi bagi pasien1,2
- Dapat mencegah kekurangan lemak pada pasien
rawat inap 3,4
- Mengurangi beban metabolisme pasien 5,6,7
- Hiperglikemia dapat dicegah 5,6,7
- Pada pasien PPOK dapat mencegah terjadinya
asidosis 5,6,7
- Sangat berguna bagi pasien yang tidak
memungkinkan masuknya lipid melalui oral 5,6,7
Ref.
1. Singer P.,et.al.,Clinical Nutrition 28 (2009) 387-400
2. Ed/Japanese Society for Parenteral and Enteral Nutrition:Komedikaru Notameno Jomyaku Keicho Eiyo Handobukku 2008;Nankodo:p285-395
3. ASPEN:JPEN 2002;26(1)sup:31-32
4. Tetsuya Tsukamoto,et al;JJPEN 1992;14 (2) : 135-138
5. Ed/Japanese Society for Parenteral and Enteral Nutrition,Fujiyama Y,Sasaki M: Komedikaru Notameno Jomyaku Keicho Eiyo Handobukku 2008 ;p311-317
6. Ed./Japanese Society for Parenteral and Enteral Nutrition, wasa K: Komedikaru Notameno Jomyaku Keicho Eiyo Handobukku 2008;Nankodo p305-308
7. Ed./Japanese Society for Parenteral and Enteral Nutrition, wasa K: Komedikaru Notameno Jomyaku Keicho Eiyo Handobukku 2008;Nankodo p318-320
OTSULIP 20 %
50 g Soybean Oil and 3 g Ovolecithin
NPC/N 167
※Larutan Lipid tidak boleh di campur dengan larutan lain
OTSULIP 20 %
50 g Soybean Oil and 3 g Ovolecithin